Reform Vs. Improvements: No Decision Yet On Fate Of EU Advanced Therapies Law
This article was originally published in The Pink Sheet Daily
Regulatory framework for gene therapy and tissue-engineered products is seen as inflexible and unclear, but policymakers have yet to decide on whether to fix what's there or aim for a legislative change.
Register for our free email digests: